Pediatric short bowel syndrome: redefining predictors of success

Area of Science:

• Pediatric Gastroenterology
• Neonatology
• Surgical Outcomes

Background:

• Pediatric short bowel syndrome (SBS) is associated with significant morbidity and mortality.
• Limited studies exist on predictors of survival and parenteral nutrition (PN) weaning in pediatric SBS.
• This study analyzes outcomes in a large cohort of SBS infants to identify key predictive factors.

Purpose of the Study:

• To determine predictors of survival in pediatric short bowel syndrome (SBS) patients.
• To identify factors predicting successful weaning from parenteral nutrition (PN) in pediatric SBS.
• To enhance the prediction of outcomes for better management of pediatric SBS.

Main Methods:

• Multivariate Cox proportional hazards analysis was performed on 80 pediatric SBS patients.
• Primary outcomes included survival and the ability to wean off PN.
• Nonsignificant covariates were eliminated, with P < 0.05 considered significant.

Main Results:

• Survival was observed in 72.5% and PN weaning in 63.8% of patients over a mean follow-up of 5.1 years.
• Cholestasis (conjugated bilirubin ≥ 2.5 mg/dL) was the strongest predictor of mortality (RR 22.7, P = 0.005).
• Age-adjusted small bowel length (<10% of normal) predicted mortality (RR 5.7, P = 0.003), while longer length (≥10% of normal) predicted PN weaning (RR 11.8, P = 0.001).
• Presence of the ileocecal valve (ICV) strongly predicted PN weaning (RR 3.9, P < 0.0005) but not survival.

Conclusions:

• Cholestasis and age-adjusted small bowel length are critical predictors of mortality in pediatric SBS.
• Age-adjusted small bowel length and the presence of the ICV are key predictors for weaning from PN.
• These findings facilitate improved outcome prediction and management strategies for pediatric SBS.